Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123M
-
Number of holders
-
176
-
Total 13F shares, excl. options
-
67.7M
-
Shares change
-
+4.02M
-
Total reported value, excl. options
-
$561M
-
Value change
-
+$34.5M
-
Put/Call ratio
-
0.66
-
Number of buys
-
84
-
Number of sells
-
-82
-
Price
-
$8.29
Significant Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q1 2022
193 filings reported holding CPRX - CATALYST PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2022.
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) has 176 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.7M shares
of 123M outstanding shares and own 54.96% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (8.37M shares), BlackRock Inc. (7.44M shares), VANGUARD GROUP INC (4.73M shares), STATE STREET CORP (4.62M shares), LSV ASSET MANAGEMENT (3.7M shares), ROYCE & ASSOCIATES LP (2.26M shares), DIMENSIONAL FUND ADVISORS LP (2.15M shares), GEODE CAPITAL MANAGEMENT, LLC (1.75M shares), ACADIAN ASSET MANAGEMENT LLC (1.52M shares), and PRUDENTIAL FINANCIAL INC (1.43M shares).
This table shows the top 176 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.